Revolution Medicines (RVMD) Payables (2018 - 2025)
Historic Payables for Revolution Medicines (RVMD) over the last 8 years, with Q3 2025 value amounting to $74.8 million.
- Revolution Medicines' Payables rose 20605.58% to $74.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.8 million, marking a year-over-year increase of 20605.58%. This contributed to the annual value of $54.4 million for FY2024, which is 1191.33% down from last year.
- Revolution Medicines' Payables amounted to $74.8 million in Q3 2025, which was up 20605.58% from $56.8 million recorded in Q2 2025.
- In the past 5 years, Revolution Medicines' Payables registered a high of $74.8 million during Q3 2025, and its lowest value of $9.6 million during Q1 2021.
- In the last 5 years, Revolution Medicines' Payables had a median value of $24.5 million in 2024 and averaged $30.5 million.
- Per our database at Business Quant, Revolution Medicines' Payables crashed by 1745.37% in 2024 and then soared by 20605.58% in 2025.
- Quarter analysis of 5 years shows Revolution Medicines' Payables stood at $14.1 million in 2021, then surged by 51.57% to $21.3 million in 2022, then surged by 190.0% to $61.8 million in 2023, then dropped by 11.91% to $54.4 million in 2024, then soared by 37.52% to $74.8 million in 2025.
- Its last three reported values are $74.8 million in Q3 2025, $56.8 million for Q2 2025, and $47.5 million during Q1 2025.